-
Product Insights
Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Drugs In Development, 2022, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood...
-
Product Insights
Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Peritoneal cancer develops in the peritoneum, a thin, delicate sheet that lines the inside wall of the abdomen and covers the uterus, and extends over the bladder and rectum. Peritoneal cancer usually manifests with abdominal distention and diffuse nonspecific abdominal pain secondary to ascites. Peritoneal cancer symptoms may include shortness of breath, rectal bleeding, loss of appetite, frequent urination, constipation, nausea or diarrhea, and feeling of fullness, even after a light meal. Treatment includes options such as chemotherapy, surgery, biological...
-
Product Insights
Malignant Mesothelioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Malignant Mesothelioma pipeline market report provides a comprehensive overview of the therapeutics under development for Malignant Mesothelioma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Malignant Mesothelioma and features...
-
Sector Analysis
Japan Spinal Surgery Market Size (Value, Volume, ASP) by Segments (Minimal Invasive Spinal Devices, Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems and Vertebral Compression Fracture Repair Devices), Share and Forecast, 2015-2025
GlobalData’s “Japan Spinal Surgery Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Japan Spinal Surgery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Minimal Invasive Spinal Devices, Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems and Vertebral Compression Fracture Repair Devices. The Japan Spinal Surgery Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD)...
-
Sector Analysis
Asia-Pacific Other Joint Reconstruction Market Size (Value, Volume, ASP) by Segments (Ankle Replacement, Digits Replacement, Elbow Replacement and Wrist Replacement), Share and Forecast, 2015-2025
GlobalData’s “Asia - Pacific Other Joint Reconstruction Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Asia - Pacific Other Joint Reconstruction market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Ankle Replacement, Digits Replacement, Elbow Replacement and Wrist Replacement. The Asia - Pacific Other Joint Reconstruction Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD)...
-
Sector Analysis
Asia-Pacific Spinal Surgery Market Size (Value, Volume, ASP) by Segments (Minimal Invasive Spinal Devices, Spinal Fusion, Vertebral Compression Fracture Repair Devices and Others), Share and Forecast, 2015-2025
GlobalData’s “Asia - Pacific Spinal Surgery Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Asia - Pacific Spinal Surgery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Minimal Invasive Spinal Devices, Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems and Vertebral Compression Fracture Repair Devices. The Asia - Pacific Spinal Surgery Market report provides key information and data on: • Annualized market revenues (USD),...
-
Sector Analysis
Japan Orthopedic Devices Market Size (Value, Volume, ASP) by Segments (Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction and Others), Share and Forecast, 2015-2025
GlobalData’s “Japan Orthopedic Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Japan Orthopedic Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools and Consumables, Other Joint Reconstruction, Shoulder Replacement, Spinal Surgery and Trauma Fixation. The Japan Orthopedic Devices Market report provides key information and...
-
Sector Analysis
Japan Cardiovascular Devices Market Outlook to 2025 – Aortic and Vascular Graft Devices, Atherectomy Devices, Cardiac Assist Devices and Others
GlobalData’s “Japan Cardiovascular Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Japan Cardiovascular Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Aortic and Vascular Graft Devices, Atherectomy Devices, Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Clot Management Devices, Electrophysiology Devices, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The Japan Cardiovascular Devices Market report provides...
-
Sector Analysis
Gene Therapy in Oncology
Unlike conventional treatments such as chemotherapy, gene therapy combines reduced treatment duration (one time treatment in some cases) with higher chances of cure in oncology. This novel therapeutic approach requires direct delivery of genetic material to the patient or in vitro genetic modification of patient cells and subsequent delivery to the patient, which is an uncharted territory in oncology and will necessitate the implementation of new regulatory guidelines and restructuring of the existing treatment algorithms in various oncology indications. In...
-
Product Insights
Malignant Mesothelioma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Mesothelioma clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Mesothelioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...